HC Wainwright & Co. Initiates Coverage On iBio with Buy Rating, Announces Price Target of $7

Benzinga Newsdesk www.benzinga.com Positive 53.3%

Neg 0% Neu 0% Pos 53.3%

HC Wainwright & Co. analyst Ananda Ghosh initiates coverage on iBio (NASDAQ:IBIO) with a Buy rating and announces Price Target of $7.